Prentice Hg
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation 10
- Acute Myeloid Leukemia Research 4
- Transplantation top 10%
-
- CAR-T cell therapy research 2
-
- Chronic Lymphocytic Leukemia Research 2
-
- Acute Lymphoblastic Leukemia research 3
-
- Nausea and vomiting management 2
-
- Cytomegalovirus and herpesvirus research 2
-
- Complementary and Alternative Medicine Studies 2
- Co-authors
- David KeelingP SwenyK. GaneshaguruDario CampanaVijay Gandhi LingaH JaniC. CollisG Jánossy
- Cited by
- HematologyTransplantationImmunology
- Journals
- Transplantation Proceedings (1 paper)PubMed Central (1 paper)PubMed (18 papers)
- Partner nations
- United KingdomUnited StatesSweden
In The Last Decade
Prentice Hg
20 papers receiving 586 citations
Peers
Comparison fields: 5 of 59
- Hematology 354
- Transplantation 43
- Immunology 145
- Oncology 177
- Genetics 68
Countries citing papers authored by Prentice Hg
This map shows the geographic impact of Prentice Hg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prentice Hg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prentice Hg more than expected).
Fields of papers citing papers by Prentice Hg
This network shows the impact of papers produced by Prentice Hg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prentice Hg. The network helps show where Prentice Hg may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Prentice Hg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Granisetron in the prevention of irradiation-induced emesis. | 1995 | 30 |
| 2 | Expression of the multidrug resistance-associated protein (MRP) in acute leukaemia. | 1994 | 90 |
| 3 | The role of immunotherapy in bone marrow transplantation for acute myeloid leukemia. | 1994 | 1 |
| 4 | Value of routine surveillance cultures for detection of CMV pneumonitis following bone marrow transplantation. | 1993 | 16 |
| 5 | Granisetron, a selective 5-HT3 receptor antagonist, for the prevention of radiation induced emesis during total body irradiation. | 1991 | 35 |
| 6 | Post-remission treatment in acute myeloid leukemia: chemotherapy or autologous or allogeneic bone marrow transplantation. | 1990 | 5 |
| 7 | T-cell depletion in allogeneic bone marrow transplantation: progress and problems. | 1990 | 24 |
| 8 | A role of herpes virus serology for the development of acute graft-versus-host disease. Leukaemia Working Party of the European Group for Bone Marrow Transplantation. | 1990 | 39 |
| 9 | Autologous bone marrow transplantation with monoclonal antibody purged marrow for high risk acute lymphoblastic leukemia. | 1989 | 46 |
| 10 | Emergency response to nuclear and radiation accidents. | 1989 | 5 |
| 11 | Correlation of immunophenotype with rearrangement of T cell antigen receptor beta and gamma genes in acute lymphoblastic leukemia of adults. | 1988 | 19 |
| 12 | Haemolytic uraemic syndrome after bone marrow transplantation: an adverse effect of total body irradiation? | 1988 | 99 |
| 13 | Rearrangement of immunoglobulin and T cell antigen receptor genes in acute myeloid leukemia with lymphoid-associated markers. | 1987 | 50 |
| 14 | T cell depletion in allogeneic bone marrow transplantation. | 1987 | 16 |
| 15 | T lymphocyte regeneration after transplantation of T cell depleted allogeneic bone marrow. | 1986 | 35 |
| 16 | The use of monoclonal antibodies in graft versus host disease prevention. | 1986 | 2 |
| 17 | Mitoxantrone in relapsed and refractory acute leukemia. | 1984 | 35 |
| 18 | OKT3 incubation of donor marrow for prophylaxis of acute graft-vs.-host disease (GvHD) in allogeneic bone marrow transplantation. | 1982 | 5 |
| 19 | Treatment of Ewing's sarcoma with high-dose melphalan and autologous bone marrow transplantation. | 1981 | 61 |
| 20 | Limited activity of ICRF-159 in advanced acute leukemia. | 1979 | 9 |
About Prentice Hg
Prentice Hg is a scholar working on Hematology, Complementary and alternative medicine and Oncology, having authored 20 papers that have together received 622 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (10 papers), Acute Myeloid Leukemia Research (4 papers), Acute Lymphoblastic Leukemia research (3 papers), Nausea and vomiting management (2 papers), CAR-T cell therapy research (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Cytomegalovirus and herpesvirus research (2 papers) and Complementary and Alternative Medicine Studies (2 papers). The work is most often cited by research in Hematology (354 citations), Transplantation (43 citations) and Immunology (145 citations). Prentice Hg has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include David Keeling, P Sweny, K. Ganeshaguru, Dario Campana, Vijay Gandhi Linga, H Jani, C. Collis, G Jánossy, Gregory K. Robbins and Lennart Boström. Their work appears in journals such as Transplantation Proceedings, PubMed Central and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.